ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Amicus Therapeutics Inc

Amicus Therapeutics Inc (FOLD)

9,83
0,05
(0,51%)
Geschlossen 07 Februar 10:00PM
9,83
0,00
( 0,00% )
Vor Marktöffnung: 10:40AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
9,83
Gebot
9,10
Fragen
9,99
Volumen
-
0,00 Tagesbereich 0,00
8,785 52-Wochen-Bereich 14,03
Marktkapitalisierung
Handelsende
9,83
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
2.280.579
Ausgegebene Aktien
298.805.773
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-19,38
Gewinn pro Aktie (EPS)
-0,51
Erlöse
399,36M
Nettogewinn
-151,58M

Über Amicus Therapeutics Inc

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It... Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Amicus Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FOLD. The last closing price for Amicus Therapeutics was US$9,83. Over the last year, Amicus Therapeutics shares have traded in a share price range of US$ 8,785 to US$ 14,03.

Amicus Therapeutics currently has 298.805.773 shares in issue. The market capitalisation of Amicus Therapeutics is US$2,94 billion. Amicus Therapeutics has a price to earnings ratio (PE ratio) of -19.38.

FOLD Neueste Nachrichten

Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025

PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 20 posters across its development programs will be included...

Amicus Therapeutics Launches Amicus Ignite, a Proactive Community Funding Programme for Initiatives That Support People Living With Pompe Disease

Funding of up to €20,000 (or local currency equivalent), per application, for a limited number of projects is available to organisations and projects located outside of the United States...

Amicus Therapeutics Reports Preliminary 2024 Revenue and Provides 2025 Strategic Outlook

2024 Total Revenue of $528M, Representing Significant Growth of 32% Year-Over-Year1 Strong and Growing Demand for Galafold® and Pombiliti® + Opfolda® Total Revenue Growth of 17-24% at CER Expected...

Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at the 43rd...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.22.076843198349.639.959.3917555799.72709482CS
40.495.246252676669.349.958.78521350659.46196676CS
12-0.3-2.9615004935810.1310.3558.78522805799.63497018CS
26-0.21-2.0916334661410.0412.568.785240868910.56533863CS
52-3.14-24.209714726312.9714.038.785261247110.84804682CS
1560.829.100998890129.0114.575.91270798610.94908985CS
260-0.68-6.4700285442410.5125.395.91269004211.62542896CS

FOLD - Frequently Asked Questions (FAQ)

What is the current Amicus Therapeutics share price?
The current share price of Amicus Therapeutics is US$ 9,83
How many Amicus Therapeutics shares are in issue?
Amicus Therapeutics has 298.805.773 shares in issue
What is the market cap of Amicus Therapeutics?
The market capitalisation of Amicus Therapeutics is USD 2,94B
What is the 1 year trading range for Amicus Therapeutics share price?
Amicus Therapeutics has traded in the range of US$ 8,785 to US$ 14,03 during the past year
What is the PE ratio of Amicus Therapeutics?
The price to earnings ratio of Amicus Therapeutics is -19,38
What is the cash to sales ratio of Amicus Therapeutics?
The cash to sales ratio of Amicus Therapeutics is 7,36
What is the reporting currency for Amicus Therapeutics?
Amicus Therapeutics reports financial results in USD
What is the latest annual turnover for Amicus Therapeutics?
The latest annual turnover of Amicus Therapeutics is USD 399,36M
What is the latest annual profit for Amicus Therapeutics?
The latest annual profit of Amicus Therapeutics is USD -151,58M
What is the registered address of Amicus Therapeutics?
The registered address for Amicus Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Amicus Therapeutics website address?
The website address for Amicus Therapeutics is www.amicusrx.com
Which industry sector does Amicus Therapeutics operate in?
Amicus Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
UPCUniverse Pharmaceuticals Inc
US$ 0,2911
(80,81%)
41,93M
RANDRand Capital Corporation
US$ 36,74
(59,67%)
7
MGOLMGO Global Inc
US$ 0,2911
(57,35%)
38,07M
ZOOZZOOZ Power Ltd
US$ 3,22
(56,31%)
46
LCNBLCNB Corporation
US$ 23,99
(53,00%)
7
BTMDBiote Corporation
US$ 2,07
(-56,96%)
43
ANIKAnika Therapeutics Inc
US$ 8,00
(-55,03%)
20
EDRYEuroDry Ltd
US$ 6,01
(-45,01%)
4
SEPNSepterna Inc
US$ 8,01
(-43,63%)
215
PFCPremier Financial Corporation
US$ 17,01
(-39,89%)
3
UPCUniverse Pharmaceuticals Inc
US$ 0,2911
(80,81%)
41,93M
MGOLMGO Global Inc
US$ 0,2911
(57,35%)
38,07M
NIVFNewGenIvf Group Ltd
US$ 0,203
(30,88%)
20,12M
LTRYLottery com Inc
US$ 1,77
(25,53%)
11,36M
CYNCYNGN Inc
US$ 0,063
(-25,53%)
10,27M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock